Literature DB >> 11448726

Endothelins: vasoactive modulators of renal function in health and disease.

S Naicker1, K D Bhoola.   

Abstract

Vasoactive autocoids with directly opposing actions on the renal vasculature, glomerular function, and in salt and water homeostasis have been demonstrated in the kidney. In the renal cortex, endothelin (ET)-1 and angiotensin-II cause vasoconstriction, decreasing renal blood flow, and glomerular filtration rate, whereas bradykinin and atrial natriuretic peptide cause vasodilation and increase glomerular capillary permeability. ET-1 causes vasoconstriction of the afferent and efferent arteries and outer medullary descending vasa recta, thereby decreasing vasa recta and papillary blood flow, while bradykinin has the opposite effect. ET-1 stimulates cell proliferation, increasing the expression of several genes, including collagenase, prostaglandin endoperoxidase synthase, and platelet-derived growth factor. ET-1 promotes natriuresis via the ET-B receptor, causing down-regulation of the epithelial Na(+) channel in the renal tubule. Thus, ETs affect three major aspects of renal physiology: vascular and mesangial tone, Na(+) and water excretion, and cell proliferation and matrix formation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11448726     DOI: 10.1016/s0163-7258(01)00131-0

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  6 in total

1.  RGS4, a GTPase activator, improves renal function in ischemia-reperfusion injury.

Authors:  Andrew M Siedlecki; Xiaohua Jin; Winston Thomas; Keith A Hruska; Anthony J Muslin
Journal:  Kidney Int       Date:  2011-03-16       Impact factor: 10.612

2.  Endothelin-1 receptor antagonist (LU-135252) improves the microcirculation and course of TNBS colitis in rats.

Authors:  Martin Kruschewski; Tanja Anderson; Christoph Loddenkemper; Heinz J Buhr
Journal:  Dig Dis Sci       Date:  2006-07-26       Impact factor: 3.199

3.  RGS4 controls renal blood flow and inhibits cyclosporine-mediated nephrotoxicity.

Authors:  A Siedlecki; J R Anderson; X Jin; J R Garbow; T S Lupu; A J Muslin
Journal:  Am J Transplant       Date:  2009-12-02       Impact factor: 8.086

4.  Microarray analysis of multiple candidate genes and associated plasma proteins for nephropathy secondary to type 2 diabetes among Chinese individuals.

Authors:  S C Lim; J J Liu; H Q Low; N G Morgenthaler; Y Li; L Y Yeoh; Y S Wu; S K Goh; C Y Chionh; S H Tan; Y C Kon; P C Soon; Y M Bee; T Subramaniam; C F Sum; K S Chia
Journal:  Diabetologia       Date:  2009-05-05       Impact factor: 10.122

5.  Endothelin 1 gene is not a major modifier of chronic kidney disease advancement among the autosomal dominant polycystic kidney disease patients.

Authors:  Shiva Nagendra Reddy Annapareddy; Ramprasad Elumalai; Bhaskar V K S Lakkakula; Gnanasambandan Ramanathan; Soundararajan Periyasamy
Journal:  J Nephropharmacol       Date:  2015-12-09

6.  Relationship between the A(8002)G intronic polymorphism of pre-pro-endothelin-1 gene and the endothelin-1 concentration among Tunisian coronary patients.

Authors:  Abdelkader Chalghoum; Yosri Noichri; Azza Dandana; Sana Azaiez; Bruno Baudin; Gouider Jeridi; Abdelhédi Miled; Salima Ferchichi
Journal:  BMC Cardiovasc Disord       Date:  2015-11-16       Impact factor: 2.298

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.